# Solid Biosciences Inc. (SLDB) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Solid Biosciences Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/SLDB/mda/fy2025/): filed 2026-03-19; accession 0001193125-26-115928 (https://www.sec.gov/Archives/edgar/data/1707502/000119312526115928/sldb-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/SLDB/mda/fy2024/): filed 2025-03-06; accession 0000950170-25-034644 (https://www.sec.gov/Archives/edgar/data/1707502/000095017025034644/sldb-20241231.htm)
- [FY 2023 MD&A](/company/SLDB/mda/fy2023/): filed 2024-03-13; accession 0000950170-24-030508 (https://www.sec.gov/Archives/edgar/data/1707502/000095017024030508/sldb-20231231.htm)
- [FY 2022 MD&A](/company/SLDB/mda/fy2022/): filed 2023-03-23; accession 0000950170-23-009318 (https://www.sec.gov/Archives/edgar/data/1707502/000095017023009318/sldb-20221231.htm)
- [FY 2021 MD&A](/company/SLDB/mda/fy2021/): filed 2022-03-14; accession 0001564590-22-009963 (https://www.sec.gov/Archives/edgar/data/1707502/000156459022009963/sldb-10k_20211231.htm)

Back to /company/SLDB/